Accéder au contenu
Merck

Synthesis and asymmetric hydrogenation of (3E)-1-benzyl-3-[(2-oxopyridin-1(2H)-yl)methylidene]piperidine-2,6-dione.

Chemical communications (Cambridge, England) (2012-11-07)
Alexander A Bisset, Akira Shiibashi, Jasmine L Desmond, Allan Dishington, Teyrnon Jones, Guy J Clarkson, Takao Ikariya, Martin Wills
RÉSUMÉ

The synthesis of (3E)-1-benzyl-3-[(2-oxopyridin-1(2H)-yl)methylidene]piperidine-2,6-dione 5 from N-benzylglutarimide was achieved in three steps. The asymmetric hydrogenation of 4 gave either the product of partial reduction (10) or full reduction (13), depending on the catalyst which was employed, in high ee in each case. Attempts at asymmetric transfer hydrogenation (ATH) of resulted in formation of a racemic product.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Glutarimide, 98%